ArticleJournal of cancer research and clinical oncology2024

Peptide Receptor Radionuclide Therapy and clinical associations with renal and hematological toxicities and survival in patients with neuroendocrine tumors: an analysis from two U.S. medical centers.

Tao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.